Condition
Atrophy;Vaginal
Total Trials
2
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
4 treatments under study, led by Light Emitting Diode
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Unknown1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (2)
Showing 2 of 2 trials
NCT03833726Not ApplicableCompletedPrimary
Light Emitting Diode for theTreatment of Genitourinary Syndrome of Menopause Associated With Breast Cancer Treatment
NCT04902794Not ApplicableUnknownPrimary
Light Emitting Diode in the Treatment of Genitourinary Syndrome of Menopause
Showing all 2 trials
Research Network
Common Treatments
- Light Emitting Diode1
- Sham Comparator Control1
- Sham Light Emitting Diode1
- Experimental Led Group1
Active Sponsors
- University of Messina1
- Patricia Lordelo1
- Centro de Atenção ao Assoalho Pélvico1
Top Investigators
Centro de Atenção Pélvica- CAAP
Related Conditions
- Breast Cancer1